N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 1 / Phase 2 ClinicalTrials.gov

Digital STEADI Efficacy

Sponsor: Friendi.fi Corporation • ClinicalTrials.gov ID: NCT07852650

Registry updated: 2026-10-01
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The aging of the U.S. population, combined with health care workforce shortages and insufficient access to effective fall prevention and exercise programs, has contributed to a high burden of fall-related injuries in older adults, especially in those with Mild Cognitive Impairment (MCI), a precursor of Alzheimer's dementia (AD) and related dementias (ADRD). There is an urgent need for scalable, evidence-based interventions that can be delivered efficiently in the home setting. This study aims to evaluate the efficacy and impact of a comprehensive digital fall prevention program (Digital STEADI) delivered through a technology platform with two conversational agents that leverage generative artificial intelligence (gen-AI) with human oversight to increase program access, enhance adherence to clinical fall prevention protocols and best practices, and reduce fall risk among community-dwelling older adults.

Interventions

  • Digital STEADI-1 (Behavioral)
    STEADI fall risk screening, monitoring and exercise program delivered and coordinated via tablet-based avatar.
  • STEADI Standard of Care (Behavioral)
    STEADI fall risk screening, monitoring, and exercise program delivered and coordinated via paper and pencil and humans.
  • Digital STEADI-2 (Behavioral)
    STEADI fall risk screening, monitoring and exercise program delivered and coordinated via SMS chat.
  • Attentional control (Behavioral)
    Receiving CDC Healthy Living content unrelated to fall prevention plus usual geriatric care.

Eligibility criteria

Inclusion Criteria: * Montreal Cognitive Assessment (MoCA) score between 26 and 30 * Able to walk independently with or without an assistive device. * Able to rise independently from a standard desk or dining room chair without arms. * Live independently in a non-institutional or senior community setting. * Able to speak, hear and understand English * Have 20/40 vision from 10 ft with or without correction (e.g., glasses) * Willing to participate in the requirements of the research program. * Able to meet in a physical study location on Emory campus. * Screen positive for fall risk per the Stay Independent screener. Exclusion Criteria: * acute medical illness requiring hospitalization. * hospitalized in the past 1 month. * diagnosed with dementia (ADRD) or a neurodegenerative disease other than MCI (e.g., Parkinson's, multiple sclerosis). * uncontrolled congestive heart failure (requiring hospitalization in the past year and/or unable to the equivalent of one city block). * history of hospitalization for stroke in the past 1 year. * inability to perform study procedures.

Conditions

Fall Mild Cognitive Impairment (MCI) Aging

Locations

  • Emory University School of Medicine — Atlanta, Georgia, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record